What are the Risks of Cardioversion for Cancer Patients?
While cardioversion is generally safe, cancer patients may face specific risks. These can include:
Bleeding: Patients with low platelet counts or those on anticoagulants may be at higher risk for bleeding complications. Infection: Immunocompromised patients may be more susceptible to infections. Thromboembolism: Blood clots can form in the heart chambers due to arrhythmias and may dislodge during cardioversion, leading to stroke or other embolic events.
Close coordination between the cardiology and oncology teams is crucial to manage these risks effectively.
